emma.jacobson@rosemontpharma.com

At Rosemont our mission is to improve the health, quality of life and wellbeing of vulnerable patients through the development, manufacture and supply of high-quality prescription oral liquid medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are seeking to expand our range of medicines and convert our ‘specials’ to licensed products wherever possible.